Companies/Pharma

Johnson & Johnson

AdvertiserJNJ

Johnson & Johnson spent $1.60B on advertising and marketing in fiscal 2025, up 166.7% on the year before and -27% since 2019. That's 1.7% of revenue, less than in 2019: the business outgrew its marketing.

From its fiscal 2025 annual report (10-K)

$1.60Bmarketing spend, FY2025
+166.7%vs the year before
1.7%of revenue (-1.0 pts vs 2019)

Marketing spend by year

Advertising and marketing expense, $B (10-K)
FY2010: $2.40B$2.40BFY2011: $2.50B11FY2012: $2.30BFY2013: $2.50B13FY2014: $2.60BFY2016: $2.50B16FY2017: $2.50BFY2018: $2.60B18FY2019: $2.20BFY2021: $2.10B21FY2022: $1.20BFY2023: $500M23FY2024: $600MFY2025: $1.60B$1.60B25
As a share of revenue, %
1.5%3.5%FY2017: 3.3%FY2018: 3.2%FY2019: 2.7%FY2021: 2.5%FY2022: 1.5%FY2025: 1.7%1.7%11131618212325

Advertising and marketing expense: $2.40B in FY2010, $1.60B in FY2025. As a share of revenue: 3.3% in FY2017, 1.7% in FY2025. Years where the filing's revenue line isn't comparable are left out of the line.

Say vs do

We found no statement about the size of Johnson & Johnson's marketing budget on its earnings calls or in its 10-Ks, so here is its record against its peers.

What they said

No statement about the size of its marketing budget.

What they did

YearMarketing spendChangeShare of revenue
FY2025$1.60B+166.7%1.7%
FY2024$600M+20.0%0.7%
FY2023$500M-58.3%0.6%
FY2022$1.20B-42.9%1.5%
FY2021$2.10B-4.5%2.5%
FY2019$2.20B-15.4%2.7%

Against its peers. Compared with the 3 other Pharma advertisers we track (Pfizer, AbbVie, Eli Lilly): since 2019 its marketing spend went -27% (peer median +91%); its share of revenue moved -1.0 pts (median -0.5); last year +166.7% (median 0.0%).

How we check: a statement gets a verdict only when it's clearly about the size of the whole company's marketing budget over a full fiscal year; we compare it with the advertising and marketing expense in that year's 10-K. Statements about one quarter, one brand or channel, or the mix between brand and performance can't be checked against annual filings.

In the news

Peers